BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5598901)

  • 1. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 2. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the coagulation system during postoperative treatment with anticoagulants].
    Popov-Cenić S
    Med Klin; 1966 Dec; 61(49):1960-4. PubMed ID: 5973257
    [No Abstract]   [Full Text] [Related]  

  • 6. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):806-10. PubMed ID: 5023769
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of action of oral anticoagulants].
    Uszyński L
    Acta Haematol Pol; 1972; 3(2):133-9. PubMed ID: 4655612
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin therapy. 1.
    Deykin D
    N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
    [No Abstract]   [Full Text] [Related]  

  • 11. The liver and blood coagulation: physiology and pathology.
    Roberts HR; Cederbaum AI
    Gastroenterology; 1972 Aug; 63(2):297-320. PubMed ID: 4558715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the effect of anticoagulants on the kidney function].
    Lakin KM; Sergeev LV
    Farmakol Toksikol; 1967; 30(5):626-31. PubMed ID: 4175312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of neodymium 3-sulfo-isonicotinate on the mechanism of coagulation in guinea pigs and rabbits].
    Tremblay J; Archambault A
    Rev Can Biol; 1967 Mar; 26(1):1-9. PubMed ID: 6053477
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residue.
    Van der Woerd-de Lange JA; van Dam-Mieras MC; Hemker HC
    Haemostasis; 1981; 10(6):315-47. PubMed ID: 6976920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 17. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation.
    de Araújo RM; Vaz AF; Santos ME; Zingali RB; Coelho LC; Paiva PM; Correia MT; Oliva ML; Ferreira RS
    Thromb Res; 2011 Oct; 128(4):395-7. PubMed ID: 21752431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of new analytical reagents demonstrated with coumadin-modified plasma.
    Seegers WH; Elkstrom ME; Harper CA; Hassouna HI
    Bibl Haematol; 1977; 44():61-7. PubMed ID: 617784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral anticoagulant treatment; which anticoagulant?].
    Thijssen HH; Hemker HC
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1559-63. PubMed ID: 6483024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.